HC Wainwright Upgrades Aethlon Medical (NASDAQ:AEMD) to Neutral

Aethlon Medical (NASDAQ:AEMD) was upgraded by equities research analysts at HC Wainwright to a “neutral” rating in a research note issued to investors on Monday, Marketbeat.com reports.

Separately, Wall Street Zen assumed coverage on shares of Aethlon Medical in a research note on Thursday, May 15th. They issued a “sell” rating on the stock.

Aethlon Medical Price Performance

NASDAQ AEMD traded down $0.23 during trading hours on Monday, hitting $1.23. 849,754 shares of the company’s stock traded hands, compared to its average volume of 219,595. The firm’s 50-day moving average is $2.38 and its 200-day moving average is $3.62. Aethlon Medical has a 52-week low of $1.10 and a 52-week high of $8.44. The company has a market capitalization of $3.17 million, a PE ratio of -0.10 and a beta of 1.69.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Virtu Financial LLC purchased a new stake in shares of Aethlon Medical in the 4th quarter valued at approximately $81,000. Boothbay Fund Management LLC purchased a new stake in shares of Aethlon Medical in the 4th quarter valued at approximately $186,000. Sassicaia Capital Advisers LLC purchased a new stake in shares of Aethlon Medical in the 4th quarter valued at approximately $31,000. Armistice Capital LLC purchased a new stake in shares of Aethlon Medical in the 1st quarter valued at approximately $511,000. Finally, Renaissance Technologies LLC purchased a new stake in shares of Aethlon Medical in the 4th quarter valued at approximately $25,000. 1.99% of the stock is owned by hedge funds and other institutional investors.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.